RSS

Merck

A new agreement in the peptide therapeutics area between integrated drug discovery company, IRBM, and Merck (which is known as MSD outside the US and Canada) has been announced. more

News

After receiving approval for two HIV drugs, Delstrigo and Pifeltro, Merck should be expecting strong sales but probably unlikely to be at blockbuster levels, according to senior pharma analyst at GlobalData. more

Analysis

A proof of concept field trial is being performed by AT&T and Softbox in collaboration with Merck to test the viability of using connected payloads and drones to deliver temperature-sensitive medicines. more

Technology

The recent collaboration between Merck and InnoCore Pharmaceuticals for the development of a new drug delivery platform that will improve compliance could be a step forward in the delivery of biologics, according to GlobalData more

Opinion

Science and technology company, Merck, has entered into a cooperation agreement with Netherlands-based InnoCore Pharmaceuticals, for a new drug delivery platform that will aim to improve patient compliance. more

News

A label change for MSD’s (known as Merck in the US and Canada) ulcerative colitis (UC) treatment — SIMPONI (golimumab) — has received approval from the European Commission. more

News

After learning that pharma giant, Merck, has filed for a US patent for a blockchain-based system, GlobalData has been led to believe that the first applications of blockchain will initially be seen in the healthcare supply chain more

Analysis

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

Science and technology company, Merck, has entered into an agreement with HistoCyte Laboratories, for the distribution of its portfolio of cell line reference products for immunohistochemistry and in situ hybridisation. more

News

Data has been presented by AstraZeneca and Merck demonstrating clinical improvement in median radiologic progression-free survival (rPFS) with Lynparza (olaparib) in combination with abiraterone compared to abiraterone monotherapy, a standard of care more

News

Science and technology company, Merck, has announced a collaboration with Swiss contract research and service provider, Solvias, for a new monocyte activation test (MAT) kit for pyrogen detection. more

Technology

The European Medicines Agency (EMA) has approved AstraZeneca and Merck’s Lynparza (olaparib) tablets as maintenance therapy for the treatment of platinum-sensitive relapsed ovarian cancer, regardless of BRCA status. more

News

With a spring in their step, manufacturing experts from pharma and biotech descend on New York to enjoy the offerings from this year’s Interphex meeting. Here’s our brief round-up of what to see from exhibitors at the event on day one… more

News

Science and technology company, Merck, has partnered with Oxford University’s Jenner Institute to develop cost-effective vaccine manufacturing processes, aimed at speeding up vaccine availability. more

News

Merck has revealed its collaboration with US-based Medisafe, which is aimed at helping cardiometabolic patients better manage medication intake and adherence to prescribed treatment regimens through a digital offering. more

News

Science and technology company, Merck, has been named as the overall ‘Best Bioprocessing Supplier’ at the Asia-Pacific Bioprocessing Excellence Awards where it also won the sub-category of ‘Best Bioprocessing Supplier Award for Single-use Systems’. more

News

The Scottish Medicines Consortium (SMC) has issued its final advice, recommending restricted use of cladribine tablets (Mavenclad, Merck) for the treatment of highly active relapsing multiple sclerosis (MS). more

News

Data and analytics company, GlobalData, has revealed its prediction that Merck will lead the way in licensing deals for the year when considering the success of the company since 2016. more

Analysis

Two CE-marked IVD liquid biopsy tests have been launched by molecular diagnostics company, Biocartis Group. — the Idylla ctKRAS Mutation Test and the Idylla ctNRAS-BRAF Mutation Test. more

Technology

Ahead of the government’s announcement of its industrial strategy, it has been revealed that MSD (also known as Merck) will make a landmark investment into the UK’s economy through the opening of a new UK hub, for the research into future treatments. more

News